Wan et al. recently confirmed that AML Tregs have a higher pro-apoptotic ability on CD4+/CD25− T-cells compared to “normal” Tregs and a higher suppressive activity on CD4+/CD25− IFN-γ secretion compared to that of healthy controls. Here, CD4 is linked to acute myeloid leukemia.